Address Tablets 5:160 mg Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Address Tablets 5:160 mg.

Available Products of Address Tablets 5:160 mg

Address Tablets 5:160 mg 2x7's

Reg#: 081667

Description of Address Tablets 5:160 mg

Each Film Coated Tablets contains: Amlodipine5/Valsartan160 mg

Medicine Info

Pack Size: 2x7's

Company: Scotmann Pharmaceuticals

Price of Address Tablets 5:160 mg

Price: Rs. 675.36

Related Keywords

  • Address Tablets 5:160 mg price in Pakistan
  • Address Tablets 5:160 mg tablet price
  • Address Tablets 5:160 mg Capsule price
  • Scotmann Pharmaceuticals Address Tablets 5:160 mg price
  • Buy Address Tablets 5:160 mg online
  • Address Tablets 5:160 mg uses
  • Address Tablets 5:160 mg syrup price
  • Address Tablets 5:160 mg pack 2x7's cost

Address Tablets 5:160 mg 4x7's

Reg#: 081667

Description of Address Tablets 5:160 mg

Each Film Coated Tablets contains: Amlodipine5/Valsartan160 mg

Medicine Info

Pack Size: 4x7's

Company: Scotmann Pharmaceuticals

Price of Address Tablets 5:160 mg

Price: Rs. 1323.36

Related Keywords

  • Address Tablets 5:160 mg price in Pakistan
  • Address Tablets 5:160 mg tablet price
  • Address Tablets 5:160 mg Capsule price
  • Scotmann Pharmaceuticals Address Tablets 5:160 mg price
  • Buy Address Tablets 5:160 mg online
  • Address Tablets 5:160 mg uses
  • Address Tablets 5:160 mg syrup price
  • Address Tablets 5:160 mg pack 4x7's cost

Alternatives brands of Address Tablets 5:160 mg

Explore alternative brands for Address Tablets 5:160 mg below.

View Alternatives

Explore More Medicines

Address Tablets 5:80 mg

Scotmann Pharmaceuticals

MRP: Rs. 925.7946

Address Tablets 10:160 mg

Scotmann Pharmaceuticals

MRP: Rs. 792.4683

Address Tablets 10:160 mg

Scotmann Pharmaceuticals

MRP: Rs. 1552.9240

Atmos Tablets 20 mg

Scotmann Pharmaceuticals

MRP: Rs. 308.3970

Atmos Tablets 20 mg

Scotmann Pharmaceuticals

MRP: Rs. 381.8666

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!